Whats is this CA125 Blood Test?
This CA125 Ovarian Cancer Marker is present during embryonic development at the level of the coelomic epithelium and in the amniotic fluid. It is also found in a high percentage of ovarian cancer tumours of epithelial origin and can be detected in the serum of women with invasive primary disease. Therefore, conditions that can cause an increase include many that aren’t cancerous, such as menstruation and uterine fibroids. Specific cancers, including ovarian, endometrial, peritoneal, and fallopian tube types, may also cause increased levels.
Why Choose our CA125 Tumour Marker Kit?
- Deal Direct Laboratory Best Prices
- Deal Direct Laboratory Best Support
- Pre-Paid Royal Mail Tracked 24/48, Return to Lab Label included.
- Result Certificate Issued by Confidential Email (No SMS)
- While You Wait for Options for £50
- Result in 1-2 days
- MHRA Registered IVD Devices
- Support via WhatsApp during business hours
How do I order a CA125 Test Kit?
Order your kit online and once it arrive collect your sample at home.
Then, drop off the Kit in the morning to the Royal Mail Red Street Box. Use the Track24/48 Return Label to the Lab.
Lastly, once your results are ready, we will send you an email with your Result. Also you can view the report in your Dashboard.
1 BioMarker
- CA125. Measures the level in your blood.
The marker CA 125 is analysed through a blood sample taken in the morning before eating.
And the results
The equipment gives the reference values, the working method and the reagents used, and these values may differ from one laboratory to another.
High levels
Levels are elevated in ovarian and other cancers, including:
- uterine cervical;
- fallopian tube;
- pancreatic;
- breast;
- colorectal;
- lung;
- gastric, etc.
The exam shows elevated levels in non-cancerous conditions, including:
- menstruation;
- task;
- endometriosis;
- pelvic inflammatory disease;
- non-cancerous ovarian cysts;
- uterine fibroids, etc.
A decrease in level during treatment usually means the disease responds to treatment. If the levels remain the same or increase during treatment, this may mean that the disease is not responding to treatment.
Further Discussions:
Neoplastic diseases are second in global death rates. However, attempts have been made to find a malignant cell transformation as soon as possible. The substances are the tumour markers.
They can be classified into two types: cellular and humoral. However, cell markers are represented by antigens located at the level of cell membranes (cell markers in leukaemias) and hormonal or growth factor receptors.
Also, CA125 (tumour antigen) is present in the epithelium of many organs, such as the ovary, stomach, colon, kidneys, bronchi, and gall bladder. It is in amniotic fluid, high amounts of serum of pregnant women and breast milk.
High levels are a sign of other conditions. However, the test does not screen women at low risk for the disease. Also, the check is aimed at women already diagnosed with it, aiding in establishing effective treatment or identifying recurrence.
Diagnosis
The marker helps diagnose and monitor various types of cancer. Therefore, it is also considered a secondary marker for lung, pancreatic, tubal, endometrial, and endocervical diseases.
And the analysis in treatment, prognosis assessment, and ovarian disease diagnosis. However, in the presence of a pelvic mass, it can distinguish between a benign process and a malignant condition.
An exam that is best in the following cases:
- if the doctor suspects that there is a disease in the body,
- to see if the treatment is working;
- and to see if it has recurred after treatment.
Also, certain situations and conditions besides ovarian disease that can cause levels to rise are:
- diverticulitis;
- endometriosis;
- uterine fibroids;
- inflammatory bowel disease;
- menstruation;
- liver diseases;
- pelvic inflammatory disease;
- peritonitis;
- task;
- recent surgical intervention;
- ruptured ovarian cyst.
Therefore, for someone with a family history, the doctor may recommend a Lab test to screen for it. Some doctors may recommend this exam combined with a transvaginal ultrasound every six months for those at very high risk.
But if you want to take a sample at one of the clinics near me.
What are the Common CA125 Blood Test Questions?
-
Q: And what are the Ovarian Cancer symptoms?
- A: There are no symptoms in the early stages. However, you may notice abdominal discomfort, swelling and gastrointestinal symptoms in later stages. As such, getting checked will confirm the disease.
-
Q: Who can be at high risk?
- A: It can be anyone, especially if you have a family history, genetic predisposition, or have hormone replacement therapy.
-
Q: Can you feel a lump?
- A: This type of cancer cannot be discovered by yourself, only during a CA125 screen at your doctor.
-
Q: Can it spread?
- A: Yes, it can be spread to the organs surrounding the area.
-
Q: But can I still have this disease if my ovaries are removed?
- A: You cannot have this disease if your ovaries have been removed.
-
Q: Can it be prevented?
- A: Unfortunately, there is no way to prevent this disease. However, it is known that oral contraceptives can reduce the risk of it by 50% if you take them for at least five years.
-
Q: Can you be fully cured?
- A: Many women have fully recovered from this disease by changing their levels, so you must frequently get to know your Levels over the treatment time.
What is the CA125 Tumour Marker Scientific Data from the Instrument and Reagent Supplier?
Technology Method:
Fluorescence quantitative immunoassay
Limit of Detection:
Less than or equal to 5.0 mIU/mL.
Accuracy and Precision:
The relative standard deviation from the target value is ≤ 15%. The within assay CV is ≤ 15%. The between assay CV is ≤ 15%.
Measuring Range:
Validation-Active Information:
- EQA: Yes
- Inter-laboratory validations
- Periodic according to validation schedule.
- Event-triggered- QC/Calibration/New materials/Batch
Accuracy and Precision:
The accuracy of these methods is based on the relative deviation. The relative deviation is the average deviation from the actual result value.
The precision relies on the within-assay coefficient of variations and the between-assay coefficient. The within-assay coefficient of variations is the variance of the result value if the same CA125 sample was analysed again. The between assay coefficient is the variance of the result value if the same sample was reprocessed from the beginning again.
In range results:
Healthy females are expected to have a value below 35 U/mL in the serum.
Out-of-range results:
Any value above 35 U/mL is considered abnormal. Those with elevated levels may be at risk.
Page Quality Review:
Review Date : 19/01/2024
Reviewed By :
A Real Story Of Fear and Loss – Lenneke (64)
You can’t live every day with the idea that you are going to die
Seven years ago, the oncologist gave Lenneke another year. CA125 Test Diagnosis: ovarian HPV type of CA125 cancer with metastases in the lungs. Seven years later, Lenneke is still there, and the disease is stable. Currently without medication. The doctor has no explanation for it. Lenneke will see what comes of it.
Lenneke had not been ill for very long when she attended an event. She started talking to a woman who told her that she had been living with incurable HPV-related cancer for seven years. ‘That was an infinitely long time for me. Now I’m in the same situation.’
Coughing like a seal
Summer 2014. Just before the holiday, Lenneke suffered from a swollen stomach and had difficulty going to the toilet. The CA125 doctor advised her to get some from the drugstore, but the complaints persisted during the holidays. At the end of August, she gets a nasty cough. Concerned colleagues – “You cough like a seal” – thought she should go to the doctor. When two courses of antibiotics had no effect, Lenneke asked for a lung x-ray. It was immediately clear. Three litres of fluid. A day later, she heard that it was most likely metastatic OC. Terminally ill. ‘Overnight.’
No expensive medication for palliative patients
Lenneke requested a second opinion at another Hospital. Her tumour markers were very high, but there was little to nothing visible on the ultrasounds and scans except fluid in the lungs. Additional research, unfortunately, showed that it was metastatic OC. The treatment took place at another university hospital, also one of the treatment centres for OC. Lenneke received the standard treatment. Three rounds of chemotherapy, surgery and another three rounds of chemotherapy. Her DNA doctor at the time, a young woman, gave her – in the middle of the treatment period –
Another Year.
When chemo could not continue because her resistance was too low, Lenneke asked for an injection of Neulasta. This is a drug that boosts white blood cells. The doctor didn’t want to give it. “We don’t do that with patients being treated palliatively,” she said. I thought: “Well, thank you, I know that I am on palliative care” (Lenneke did receive the injection, by the way).
Fortunately, the treatment worked. ‘So good that the gynaecologist-oncologist concluded that the treatment might be considered curative. ‘Then I had to pick myself up. Because everything revolved around the last year of my life and the thought that I would die. I had been working towards that. The shadow of the last time lay over everything, and suddenly, you hear: “It’s not happening.” How was I supposed to move on with my life?’
Waiting Policy
Lenneke found a new balance to deal with the new situation. Unfortunately, three years later, the OC returned. “Now you really can’t get better anymore,” said the doctor. After a successful course of chemotherapy, Lenneke suffered a second CA125-related recurrence a year later. She was given hormone tablets, and they also worked well. The disease remained quiet for a year.
Just before the coronavirus outbreak, Lenneke had a conversation with her doctor. The cancer was active again, and Lenneke asked if the HPV Variant doctor had anything else on the table. She could choose between a new chemotherapy (still very heavy-handed at that time) or an experimental study with the protein inhibitor Olaparib. ‘I was still thinking about that because, for that test, they had to take a biopsy from my lung. That was not entirely without danger. In the middle of that thought process, the doctor called. Given the coronavirus, she did not think it was wise for me to participate in the study then.
We opted for a wait-and-see policy.
So do nothing. I have my blog onkanker.nl and also read stories from fellow sufferers. One of those ladies wrote that she had quit sugar. This allowed her to postpone chemotherapy for a year. I thought: “I’m cramped because of the corona; I have all the time to figure out how you can eat well without added sugars and few carbohydrates.”
Are you better again?
In June 2020, the situation with COVID-19 was better, and the research with Olaparib could start with a CA125 blood check and a CT scan beforehand. ‘I will never forget that nurse’s face. Because the tumour marker was normal, the scan showed that the tumours had become smaller. She consulted with the oncologist, and he said that nothing at all was going to happen for a while. Now, a year later, the tumour marker is still stable.
The oncologist thinks it’s miraculous. I recently asked her if I was better now. She didn’t want to go that far. It’s chronic.’ Of course, I know that I can’t get better anymore. But I think “chronic” sounds positive.
I just wanted to hear that.’
Although the word art of living is perfect for Lenneke, living with metastatic cancer is strange. ‘Some people don’t understand it. “You were going to die, weren’t you?” they sometimes ask me. Yes, but that didn’t happen. “But are you better?” No, not that either. It isn’t very easy. I don’t know how long this will last. Sometimes, I think it will stay that way. People sometimes ask me whether I am too preoccupied with the disease and its tests.
I assist fellow sufferers and give presentations to doctors and nurses. But then I deal with it differently. And besides, the disease won’t go away if I don’t deal with it. I have tried to turn my situation, life with OC, around in such a way that something positive can come out of it.
I have been rejected. Before my HPV illness, I was a manager at a home care organisation. This way, I could use my knowledge and skills as an expert based on experience. It’s nice to be able to do something for others and get a lot of satisfaction from it.
Getting excited about little things
Lenneke has been close to death from HPV. But it ended well. What if things go wrong again? ‘We’ll see about that again. I know what it’s like to have to tie up the ends. It’s good to talk about it and think about it. But now I’m doing well, and I’m busy living. You can’t think about death every day. That’s living at the top of your game, and no one can sustain that.
I do notice from tests that I approach the HPV Risk of life differently. Some things become much less important. At a time when things were not going well for me, my eldest son said that I had mellowed out. When I started feeling better again, I started worrying about something trivial.
Then he said, “I prefer you that way.” And I wholeheartedly agree with him. Because as long as I can still get excited about small things but also feel the drive and enthusiasm within me, I am busy with the main issues of life and not CA125-induced disease”.
Shipping and Return Policies
Appointment:
Missed appointments or cancellations less than 24 hours prior are not entitled to refunds. Rescheduling is possible but not guaranteed. Please contact the customer service prior to the appointment time to discuss cost and availability options.
Shipping & Return:
We have a 14-day return policy, which means you have 14 days after receiving your item to request a return.
To Qualify for any return, the product must be in the same condition as when you received it. Not used, not opened, unworn, in its original packaging. You will also need to send it to us with the receipt or proof of purchase.
Please return to: Medicines by MailBox, 89 Falcon Rd, London. SW11 2PF
You can read our full return policy here:
https://medicinesbymailbox.co.uk/return-policy/
We offer next day delivery; however courier delivery times are out of our control. We are unable to offer refunds for any late deliveries. But you will receive courier tracking information once your order has been dispatched. And orders placed by 1pm are dispatched on the same day.
What is the CA125 Test Kit Shipping & Return Policy?
We have a 14-day return policy, which means you have 14 days after receiving your item to request a return.
Therefore, to qualify for any return, the CA125 Ovarian Cancer kit must be in the same condition as when you received it. However, it is not used, not opened, unworn, and in its original packaging. And remember, you must also send it to us with the receipt or proof of purchase.
Then, please return your kit to Medicines Online, 89 Falcon Rd, London. SW11 2PF.
You can read our full return policy here:
https://medicinesbymailbox.com/return-policy/
We offer next-day delivery; however, courier delivery times are out of our control. We are unable to provide refunds for late deliveries. You will receive courier tracking information once your order has been dispatched. Orders placed by 1 p.m. are posted on the same day.
Principle IVD Regulatory Certification
-
MHRA Reference Number: 10271 – Unistik Lancet
-
MHRA Registration Number: 9489 – BD Microtainer Tube
Page Quality Review:
Review Date : 25/01/2024
Reviewed By :
Polly F. –
Customer service was friendly and knowledgeable. Made the process easy for me!
Mila Rose –
The kit is easy to use
Viviane B. –
It went well, the test is simple to use
Catherine –
I had not understood the results, but after customer service helped me to clarify
Natalie –
Delivery was the very next day and the results were also quick
Bella –
Online Medicines is a fabulous company! I am very grateful to them
Melanie –
Thank you for the service. They were very supportive throughout the whole process